Prenatal air pollution exposure and growth and cardio-metabolic risk in preschoolers.


Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
05 2020
Historique:
received: 07 10 2019
revised: 26 01 2020
accepted: 27 02 2020
pubmed: 21 3 2020
medline: 21 11 2020
entrez: 21 3 2020
Statut: ppublish

Résumé

We investigated the association between outdoor air pollutants exposure in the first trimester of pregnancy, and growth and cardio-metabolic risk at four years of age, and evaluated the mediating role of birth weight. We included mother-child pairs (N = 1,724) from the Spanish INMA birth cohort established in 2003-2008. First trimester of pregnancy nitrogen dioxide (NO Increased PM This comprehensive study of many growth and cardio-metabolic risk related outcomes suggests that air pollution exposure during pregnancy may be associated with delays in physical growth in the early years after birth. These findings imply that pregnancy exposure to air pollutants has a lasting effect on growth after birth and require follow-up at later child ages.

Identifiants

pubmed: 32193046
pii: S0160-4120(19)33714-6
doi: 10.1016/j.envint.2020.105619
pii:
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0
Nitrogen Dioxide S7G510RUBH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105619

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest relevant to this article to disclose.

Auteurs

Serena Fossati (S)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: serena.fossati@isglobal.org.

Damaskini Valvi (D)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

David Martinez (D)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Marta Cirach (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Marisa Estarlich (M)

CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Department of Nursing, Faculty of Nursing and Chiropody, University of Valencia; Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, Valencia, 46020, Spain.

Ana Fernández-Somoano (A)

CIBER Epidemiología y Salud Pública (CIBERESP), Spain; IUOPA-Departamento de Medicina, University of Oviedo, Oviedo, Spain; Institute of Health Research of the Principality of Asturias - Foundation for Biosanitary Research of Asturias (ISPA-FINBA), Oviedo, Spain.

Mònica Guxens (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, the Netherlands.

Carmen Iñiguez (C)

CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Department of Statistics and Computational Research, Universitat de València, Valencia, Spain.

Amaia Irizar (A)

Biodonostia Health Research Institute, Donostia, Spain.

Aitana Lertxundi (A)

CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Biodonostia Health Research Institute, Donostia, Spain; Faculty of Medicine and Nursing of the University of the Basque Country, Bilbao, Spain.

Mark Nieuwenhuijsen (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Ibon Tamayo (I)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Division of Immunology and Immunotherapy, Cima, Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.

Jesus Vioque (J)

CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Universidad Miguel Hernandez, ISABIAL-FISABIO, Alicante, Spain.

Adonina Tardón (A)

CIBER Epidemiología y Salud Pública (CIBERESP), Spain; IUOPA-Departamento de Medicina, University of Oviedo, Oviedo, Spain; Institute of Health Research of the Principality of Asturias - Foundation for Biosanitary Research of Asturias (ISPA-FINBA), Oviedo, Spain.

Jordi Sunyer (J)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Martine Vrijheid (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH